This is a Validated Antibody Database (VAD) review about mouse Cxcl1, based on 5 published articles (read how Labome selects the articles), using Cxcl1 antibody in all methods. It is aimed to help Labome visitors find the most suited Cxcl1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Cxcl1 synonym: Fsp; Gro1; KC; Mgsa; N51; Scyb1; gro
Abcam
| domestic rabbit polyclonal |
| Abcam Cxcl1 antibody (Abcam, ab269939) was used in immunohistochemistry on mouse samples (fig 1c). Front Physiol (2021) ncbi |
| domestic rabbit polyclonal |
| Abcam Cxcl1 antibody (Abcam, ab86436) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 6i, s6c). Cancer Res (2021) ncbi |
| domestic rabbit polyclonal |
| Abcam Cxcl1 antibody (Abcam, ab86436) was used in immunohistochemistry - paraffin section on human samples (fig 2a) and in western blot on human samples (fig 3c, 3d). CNS Neurosci Ther (2020) ncbi |
| domestic rabbit polyclonal |
| Abcam Cxcl1 antibody (Abcam, ab86436) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s2d). PLoS ONE (2020) ncbi |
Invitrogen
| domestic rabbit polyclonal |
| In order to test if alpha7nAChR in adipocytes may inhibit acylation stimulating protein-induced inflammation, Invitrogen Cxcl1 antibody (Thermo Fisher Scientific, PA1-32924) was used in western blot on mouse samples at 1:500 (fig 1a). Mol Med Rep (2016) ncbi |
Articles Reviewed
- Jiao Z, Wu J, Liu C, Wen B, Zhao W, Du X. Nicotinic ?7 receptor inhibits the acylation stimulating protein?induced production of monocyte chemoattractant protein?1 and keratinocyte?derived chemokine in adipocytes by modulating the p38 kinase and nuclear factor??B signaling pathways. Mol Med Rep. 2016;14:2959-66 pubmed publisher
articles
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments
